Siemens Healthineers AG stock analysis
Siemens Healthineers AG (1SHL) Stock Price & Analysis
1SHL Stock Chart & Stats
- Day’s Range
- EUR 43.55 - EUR 44.70
- 52-Week Range
- EUR 19.00 - EUR 65.00
- Previous Close
- EUR 43.34
- Volume
- N/A
- Average Volume (3M)
- 109
- Market Cap
- EUR 48.56B
- Enterprise Value
- EUR 50.98B
- Total Cash (Recent Filing)
- EUR 2.96B
- Total Debt (Recent Filing)
- EUR 14.74B
- Price to Earnings (P/E)
- 22.1
- Beta
- 0.82
- Next Earnings
- Feb 04, 2027 (Est.)
- EPS Estimate
- 0.5
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 2.29%
Bulls Say, Bears Say
Bulls Say
Recurring Installed-Base Revenue
The installed base supports recurring service, consumables, software and upgrade revenue alongside equipment sales. This mix can improve customer retention, increase revenue visibility across procurement cycles, and support durable cash generation as the company expands relationships with healthcare providers.
Core Growth And Demand
Growth across the synergetic core, combined with book-to-bill above one, indicates demand is replenishing the order pipeline rather than relying only on the existing backlog. This supports medium-term revenue visibility and reinforces the company’s position across healthcare equipment markets.
Cash Generation And Innovation
Strong multi-year free cash flow provides funding for reinvestment, debt reduction and shareholder distributions, while substantial internal R&D supports product differentiation. Together, these capabilities can sustain innovation and strengthen the company’s competitiveness over several years.
Bears Say
Diagnostics Weakness
Diagnostics remains a material drag because revenue and margins continued to decline, leaving the segment well below management’s medium-term margin ambition. A prolonged recovery would weigh on consolidated profitability and require execution of the transformation and savings programs.
China Pricing Pressure
Structural market rebasing and centralized bidding in China are pressuring both volume development and pricing, particularly in Diagnostics. These conditions can persist beyond a single quarter, making regional recovery more dependent on stabilization, portfolio strength and successful cost adaptation.
Separation And Financing Costs
The Diagnostics carve-out, Siemens deconsolidation and portfolio changes create substantial adjustment and transition costs, while refinancing raises expected financial expense. These burdens can suppress reported earnings and cash flexibility before productivity savings fully offset them.
Siemens Healthineers AG News
1SHL FAQ
What was Siemens Healthineers AG’s price range in the past 12 months?
What is Siemens Healthineers AG’s market cap?
When is Siemens Healthineers AG’s upcoming earnings report date?
How were Siemens Healthineers AG’s earnings last quarter?
Is Siemens Healthineers AG overvalued?
Does Siemens Healthineers AG pay dividends?
What is Siemens Healthineers AG’s EPS estimate?
How many shares outstanding does Siemens Healthineers AG have?
What happened to Siemens Healthineers AG’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Siemens Healthineers AG?
What is the TipRanks Smart Score and how is it calculated?
Siemens Healthineers AG Stock Smart Score
Company Description
Siemens Healthineers AG
Siemens Healthineers AG, a subsidiary of Siemens Aktiengesellschaft with its headquarters in Erlangen, Germany, is a global leader in medical technology. The company develops, produces, and distributes a comprehensive portfolio of diagnostic and therapeutic products and services, catering to healthcare providers worldwide. Its operations are organized into four distinct business segments. The Imaging segment delivers advanced medical imaging systems, encompassing magnetic resonance imaging (MRI), computed tomography (CT), X-ray technology, molecular imaging, and ultrasound solutions. The Diagnostics segment focuses on providing in-vitro diagnostic products and services for laboratory, molecular, and point-of-care applications, alongside workflow optimization tools and informatics solutions for healthcare facilities. Varian, another key segment, specializes in cancer care, offering cutting-edge technologies, services, and integrated solutions to hospital oncology departments. This includes enhancing workflow efficiency, providing clinical services and consulting, and deploying digital platforms for treatment and therapy management. Lastly, the Advanced Therapies segment supplies sophisticated products designed to facilitate image-guided minimally invasive treatments across various medical fields, such as cardiology, interventional radiology, and surgery. Its offerings include angiography systems, mobile C-arms, and a robotic-assisted platform specifically for endovascular coronary and peripheral vascular procedures. Beyond these core offerings, Siemens Healthineers also provides a suite of essential support services, such as equipment performance management, clinical education and e-learning programs, asset management, managed departmental services for laboratories and healthcare facilities, and expert consulting and digital health services.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Bernhard Montag
- Employees
- 74,600
- Website
- www.siemens-healthineers.com
- Address
- Siemensstr. 3, Forchheim, BV, 91301, DE
Siemens Healthineers AG (1SHL) Earnings & Revenues
1SHL Company Deck
1SHL Earnings Call
Earnings Call SentimentPositive
The call was broadly positive, supported by strong synergetic core growth, robust equipment demand, solid fiscal 2026 execution, innovation momentum, strategic partnerships and continued cash generation. However, the company faces meaningful challenges from Diagnostics' revenue and margin decline, China market rebasing and pricing pressure, foreign exchange and inflation, the ultrasound wind-down, higher financing costs and substantial separation-related expenses. Management presented fiscal 2027 guidance as prudent and reiterated its medium-term ambition for double-digit adjusted EPS growth.
View all IT:1SHL earnings summaries1SHL Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 16 | 5 | 1 |
| Technical Analysis | 4 | 5 | 1 |
| Moving Averages | 12 | 0 | 0 |












